DZS Announces Upcoming Investor Conference Schedule

PLANO, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- DZS Inc. (NASDAQ: DZSI), a broadband access innovator and global market leader spanning fixed and mobile optical transport and connected premises solutions for service providers and enterprises, today announced its participation in the upcoming investor conferences during November and December 2020.

• Craig Hallum’s 11^th Annual Alpha Select Conference
  Tuesday, November 17, 2020
  Virtual 1x1 meetings

• Cowen’s 7^th Annual Networking Virtual Summit
  Tuesday, December 15, 2020
  Virtual 1x1 meetings

• Oppenheimer 5G Summit
  Tuesday, December 15, 2020
  Virtual 1x1 meetings

About DZS
DZS Inc. (NSDQ: DZSI) is a broadband access innovator and global market leader spanning fixed and mobile optical transport and connected premises solutions for service providers and enterprises. A pioneer in broadband access and mobile AnyHaul platforms with over 20 million products shipped, service providers and enterprises look to DZS for the innovation that leads to future-proof networks and outstanding performance. Over 1,000 service providers, operators, and enterprises in over 100 countries have leveraged DZS innovation, open solutions, and agility to arm them with the network resources and deployment freedom they need to lead in their markets and deliver an unrivaled communications experience. With manufacturing, engineering, service and support centers of excellence spread across the globe, DZS is positioned to bring next-generation technologies and world-class solutions to service providers and enterprises who are poised to transform, compete and win.

DZS, the DZS logo, and all DZS product names are trademarks of DZS Inc. Other brand and product names are trademarks of their respective holders. Specifications, products, and/or product names are all subject to change.

For further information see: www.DZSi.com
DZS on Twitter: https://twitter.com/dzs_innovation
DZS on LinkedIn: https://www.linkedin.com/company/DZSi/

Investor Inquiries:
Ted Moreau
Vice President, Investor Relations
[email protected]

You May Also Be Interested In

• Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
• Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
• On Cancel Culture Awareness Day, Red Banyan Releases New Cancel Culture Response Playbook